home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

A New Flu Target

  December, 3 2001 9:36
your information resource in human molecular genetics
As winter descends on the Western hemisphere, public health concerns turn to influenza, which kills several people - particularly the elderly - each year. Now scientists may have discovered the specific part of the influenza virus that is responsible for killing host immune cells sent to destroy it. In doing so, they may have pinpointed a target for new flu therapies (Nature Medicine).

Jonathan Yewdell and colleagues at the US National Institute of Allergy and Infectious Diseases have discovered that a peptide segment within the virus called PB1-F2 is responsible for triggering cell death (apoptosis) in immune cells of the host. This same fragment does not, however, contribute to the ability of the virus to infect cells.

Robert Lamb and Makoto Takeda of Northwestern University, Illinois, discuss the ability of the influenza virus to mutate and develop new strategies of infection in an accompanying News & Views article.

Author contact:
Dr. Jonathan W. Yewdell
Laboratory of Viral Diseases
National Institute of Allergy and Infectious Diseases
Bethesda, MD
Phone: +1 301-496-7533
Fax: +1 301 402 7362
E-mail: jyewdell@nih.gov

Dr. Robert A. Lamb
Howard Hughes Medical Institute
Northwestern University
Deptartments of Biochemistry, Molecular Biology and Cell Biology
Evanston, IL
Phone: +1 847 491 5433
Fax: +1 847 491 2467
Email: ralamb@northwestern.edu

(C) Nature Medicine press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.